| NCT Number | NCT06512363 |
| Lead Sponsor | Nanjing Chia-tai Tianqing Pharmaceutical |
| Conditions | Chronic Insomnia |
| Enrollment | 280 participants |
| Start Date | 2024-08 |
| Primary Completion | 2026-12 (estimated) |
| Study Completion | 2026-12 (estimated) |
| Updated on ClinicalTrials.gov | 2024-07-22 |